DrugPatentWatch Database Preview
Drugs in Development Information for Urapidil
Summary for Urapidil
| US Patents | 857 |
| International Patents | 7,619 |
| US Patent Applications | 1,626 |
| WIPO Patent Applications | 1,014 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 1 (2017-06-15) |
| Vendors | 52 |
US Patents for Urapidil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Urapidil | ➤ Sign Up | Double-acylated GLP-1 derivatives | Novo Nordisk A/S (Bagsvaerd, DK) | ➤ Sign Up |
| Urapidil | ➤ Sign Up | Double-acylated GLP-1 derivatives | Novo Nordisk A/S (Bagsvaerd, DK) | ➤ Sign Up |
| Urapidil | ➤ Sign Up | Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure | CL Pharma Aktiengesellschaft (Linz, AT) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Urapidil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Urapidil | China | 104519902 | 2032-05-08 | ➤ Sign Up |
| Urapidil | European Patent Office | 2846823 | 2032-05-08 | ➤ Sign Up |
| Urapidil | Japan | 2015517477 | 2032-05-08 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
